CLINICAL_TRIALS
trial_result
· 2021-07-07
Clinical Trial Update: Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis [Phase 2]
Summary
Phase 2 trial investigating hematin to prevent post-ERCP acute pancreatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Erasme University Hospital | Conditions: Post-ERCP Acute Pancreatitis | Phase 2 | Status: COMPLETED